Procalcitonin and Brain Natriuretic Peptides in Patients With Chronic Kidney Disease.

CompletedOBSERVATIONAL
Enrollment

79

Participants

Timeline

Start Date

December 26, 2018

Primary Completion Date

April 30, 2022

Study Completion Date

April 30, 2022

Conditions
Kidney Failure, Chronic
Interventions
DIAGNOSTIC_TEST

Brain Natriuretic Protein (BNP) and Procalcitonin (PCT) blood tests

"For patients with suspected infection, PCT levels will be drawn at the time of suspected infection and again at the start of the next HD treatment.~For patients with shortness of breath, PCT and BNP levels will be drawn at the time of the complaint and again at the start of the next HD treatment."

Trial Locations (1)

10021

The Rogosin Institute, New York

All Listed Sponsors
collaborator

Weill Medical College of Cornell University

OTHER

lead

The Rogosin Institute

OTHER

NCT03698877 - Procalcitonin and Brain Natriuretic Peptides in Patients With Chronic Kidney Disease. | Biotech Hunter | Biotech Hunter